| Literature DB >> 18263758 |
Jelena Maletkovic1, Raphael Schiffmann, J Rafael Gorospe, Erynn S Gordon, Michelle Mintz, Eric P Hoffman, Gulay Alper, David R Lynch, Bhim S Singhal, Cary Harding, Hernan Amartino, Candida M Brown, Alicia Chan, Deborah Renaud, Michael Geraghty, Lloyd Jensen, Nesrin Senbil, Nadja Kadom, Javad Nazarian, Thomas Hartka, Hiroki Morizono, Adeline Vanderver.
Abstract
Eukaryotic initiation factor 2B (eIF2B)-related disorders are heritable white matter disorders with a variable clinical phenotype (including vanishing white matter disease and ovarioleukodystrophy) and an equally heterogeneous genotype. We report 9 novel mutations in the EIF2B genes in our subject population, increasing the number of known mutations to more than 120. Using homology modeling, we have analyzed the impact of novel mutations on the 5 subunits of the eIF2B protein. Although recurrent mutations have been found at CpG dinucleotides in the EIF2B genes, the high incidence of private or low frequency mutations increases the challenge of providing rapid genetic confirmation of this disorder, and limits the application of EIF2B screening in cases of undiagnosed leukodystrophy.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18263758 DOI: 10.1177/0883073807308705
Source DB: PubMed Journal: J Child Neurol ISSN: 0883-0738 Impact factor: 1.987